Propranolol inhibits bile acid and fatty acid stimulation of cyclic AMP in human colon.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001647:Bile Acids and Salts / Q000037:antagonists & inhibitors*; D002395:Catecholamines / Q000494:pharmacology; D002793:Cholic Acids / Q000037:antagonists & inhibitors; D003106:Colon / Q000187:drug effects*; D000242:Cyclic AMP / Q000378:metabolism*; D003840:Deoxycholic Acid / Q000037:antagonists & inhibitors; D004837:Epinephrine / Q000494:pharmacology; D005227:Fatty Acids / Q000037:antagonists & inhibitors*; D006801:Humans; D066298:In Vitro Techniques; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D009829:Oleic Acids / Q000037:antagonists & inhibitors; D011433:Propranolol / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D013229:Stearic Acids / Q000037:antagonists & inhibitors
D001647:Bile Acids and Salts; D002395:Catecholamines; D002793:Cholic Acids; D005227:Fatty Acids; D009829:Oleic Acids; D013229:Stearic Acids; D003840:Deoxycholic Acid; D011433:Propranolol; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D009638:Norepinephrine; D004837:Epinephrine